In order to promote the transformation and clinical development of clinical mass spectrometry, the preparatory launching ceremony of the China-US Precision Medical Clinical Mass Spectrometry Summit and the 'Clinical Mass Spectrometry Research and Industry Alliance' will be held in Dalian on September 5, 2018.
Professor Wang Chengbin, Chairman of the Chinese Medical Association Laboratory Medicine Branch, Professor Fu Weiling, Chairman of the Medical Scientific Committee of the Chinese People's Liberation Army Medical Science Committee, Professor Zhu Yusheng, Chairman of the American AACC Clinical Translation Science Division, will attend the conference and speak. At the same time, Lawrence Berkeley Professor Trent Northen, Director of the National Laboratory Metabolomics Technology Center, Director Guo Yan, Director of the Laboratory of Zhongshan Hospital, Fudan University, Professor Xu Guowang, Research Fellow, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, and Professor Li Yan, Research Fellow, Institute of Biophysics, Chinese Academy of Sciences, will share their respective Success experience and perspective on industry development.
In addition, during the preparations for the alliance, Professor Zhang Yukui, Professor Chen Hongyuan, Professor Ma Yinfa, Professor Zhao Yingming, Professor Wang Zeneng, Professor Yang Yuyuan, Professor Lu Haojie and other senior experts in the mass spectrometry industry were also supported. Their support will definitely become industrial development. The source of strength and strength.
Health is an inevitable requirement for the all-round development of mankind and a basic condition for economic and social development. Achieving national health and longevity is an important symbol of the country's prosperity and national rejuvenation, and the common aspiration of the people of all nationalities in the country. China's 2030's Planning Outline, raising people's health and promoting healthy China's construction has been mentioned at an unprecedented new height.
Clinical mass spectrometry has progressed rapidly in recent years and has gradually evolved from scientific research to industrialization. The 'Clinical Mass Spectrometry Research and Industry Alliance' (hereinafter referred to as the Alliance) has also emerged in such an era. It is well known that clinical mass spectrometry and the second generation Sequencing, precision imaging and called the three major detection tools for precision medicine. Clinical mass spectrometry can replace biochemistry, immunization for accurate detection of existing clinical markers, and dynamic and accurate monitoring of proteome and metabolome from the molecular layer. To achieve real disease early warning and accurate diagnosis. After the establishment of the alliance, it will focus on the industrialization, standardization and standardization of the manufacture and application of clinical mass spectrometry, and promote clinical mass spectrometry technology to make more contributions to human health.
Professor Fuling
'This year is the first year of the China-US Precision Medical Clinical Mass Spectrometry Summit in China. It has established a communication platform for clinical mass spectrometry research for experts in the clinical medical field. I am very pleased to see many industry colleagues actively responding to this forum. In order to promote the development of China's clinical mass spectrometry technology, in addition, China's mass spectrometry development is entering a 'new era', and the establishment of clinical mass spectrometry research and industry alliance in this era will promote the clinical application of mass spectrometry technology and promote the development of precision medicine. , Serving the National Health and Disease Treatment Strategy. ' ——President Fu Weiling
Introduction to Professor Fu Ling
Chairman of the Medical Scientific Committee of the Chinese People's Liberation Army Medical Scientific Committee
Chairman of the Chinese Society of Research Hospitals
Vice Chairman of the Chinese Medical Association Inspection Medicine Branch
meeting time:
September 5, 2018 16:00-20:00
Meeting place:
Grand Ballroom of Grand Hyatt Dalian (33, C3 District, Xinghai Square, Shahekou District, Dalian, 0411-39881234)
Meeting contact:
Lin Zhaoqiu